Pure Global

Carbonhydrate Antigen 19-9 (eCLIA) - ARCSA Registration e1d65f0325a9fd55968c49f1c28fa75f

Access comprehensive regulatory information for Carbonhydrate Antigen 19-9 (eCLIA) in the Ecuador medical device market through Pure Global AI's free database. This III medical device is registered under ARCSA ID e1d65f0325a9fd55968c49f1c28fa75f and manufactured by SHENZHEN LIFOTRONIC TECHNOLOGY CO., LTD.. The device was registered on June 04, 2021.

This page provides complete registration details including product type (In Vitro Diagnostic), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.

Free Database
Powered by Pure Global AI
ARCSA Official Data
III
e1d65f0325a9fd55968c49f1c28fa75f
Carbonhydrate Antigen 19-9 (eCLIA)
ARCSA ID: e1d65f0325a9fd55968c49f1c28fa75f
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Device Classification
Risk Class
III
Product Type
In Vitro Diagnostic
Brand Name
LIFOTRONIC
Commercial Name
19-096 IVD Reagents/Kits, Immunoassay, Tumor Marker
Registration Information
Analysis ID
e1d65f0325a9fd55968c49f1c28fa75f
Registration Date
June 04, 2021
Expiration Date
June 04, 2026
Product Use

IMMUNOASSAY FOR THE QUANTITATIVE DETERMINATION OF CARBOHYDRATE ANTIGEN 19-9 (CA19-9) IN HUMAN SERUM AND PLASMA AND TO CONTROL THE THERAPEUTIC EFFECT OF PANCREAS AND OTHER MALIGNANT TUMORS OF THE DIGESTIVE TRACT.

Manufacturer
City
SHENZHEN
Country
CHINA
Address
4TH FLOOR, BUILDING 15, 1008 SONGBAI ROAD, NANSHAN DISTRICT, SHENZHEN, 518055, CHINA
Product Owner
Name
SHENZHEN LIFOTRONIC TECHNOLOGY CO., LTD.
Country
CHINA
Authorized Representative
Address
JUAN PICALLO OE1-157 AND TINOCOCHA
Phone
22525424